Latest Articles

Publication Date
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Finance

Published: March 19, 2025, 11 a.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - MSN

Investigational ADC Shows Promise in Advanced Endometrial Cancer MSN

Published: March 19, 2025, 1:18 a.m.
Analysis of risk factors for recurrence after laparoscopic myomectomy: A retrospective study.

At present, there is unclear on the risk factors of recurrence after myomectomy. In this study, we hope to provide reference for the choice of treatment for patients with uterine …

Published: March 19, 2025, 12:17 a.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - Medpage Today

Investigational ADC Shows Promise in Advanced Endometrial Cancer Medpage Today

Published: March 18, 2025, 8:07 p.m.
The Importance of Spotting Endometrial Cancer - Curetoday.com

The Importance of Spotting Endometrial Cancer Curetoday.com

Published: March 18, 2025, 3:24 p.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - OBR Oncology

Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups OBR Oncology

Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - Oncology News Central

Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups Oncology News Central

Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - oncologynewscentral.com

Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups oncologynewscentral.com

Published: March 18, 2025, 10:24 a.m.
(PDF) Association Between Hepatic Steatosis Index and Endometrial Cancer Risk: A Cross-Sectional Study - ResearchGate

(PDF) Association Between Hepatic Steatosis Index and Endometrial Cancer Risk: A Cross-Sectional Study ResearchGate

Published: March 18, 2025, 5:59 a.m.
Potential Role of Menstrual Fluid-Derived Small Extracellular Vesicle Proteins in Endometriosis Pathogenesiss.

Endometriosis, a chronic debilitating disease affects 1 in 7-10 girls and women, who have symptoms of severe chronic pain and subfertility and significantly impacts the overall quality of life. Currently, …

Published: March 18, 2025, 12:13 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!